Analysis of CD28 and CTLA-4 gene polymorphisms in Turkish patients with Behcet's disease

International Journal of Immunogenetics

Volumn 34, Issue 1, 2007, Pages 45-49

  Gunesacar, R ^a   Erken, E ^a   Bozkurt, B ^a   Ozer, H T ^a   Dinkci, S ^a   Erken, E G ^a   Ozbalkan, Z ^b  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADULT; ARTICLE; BEHCET DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENOTYPE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; TURKEY (REPUBLIC);

ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; BEHCET SYNDROME; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; TURKEY;

EID: 33846905082     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2007.00655.x     Document Type: Article

References (35)

1. Ahmed, S., Ihara, K., Kanemitsu, S., Nakashima, H., Otsuka, T., Tsuzaka, K. et al. (2001) Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Rheumatology, 40, 662.
2. Ahmad, T., Wallace, G.R., James, T., Neville, M., Bunce, M., Mulcahy-Hawes, K. et al. (2003) Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms? Arthritis and Rheumatism, 48, 807.
3. Boiardi, L., Salvarani, C., Casali, B., Olivieri, I., Ciancio, G., Cantini, F. et al. (2001) Intercellular adhesion molecule-1 gene polymorphisms in Behçet's disease. Journal of Rheumatology, 28, 1283.
4. Deichmann, K., Heinzmann, A., Bruggenolte, E., Forster, J., Kuehr, J. (1996) An Mse I RFLP in the human CTLA4 promotor. Biochemical and Biophysical Research Communications, 225, 817.
5. Evereklioglu, C. (2005) Current concepts in the etiology and treatment of Behçet's disease. Survey of Ophthalmology, 50, 297.
6. Freysdottir, J., Lau, S.H. & Fortune, F. (1999) λδ T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS). Clinical and Experimental Immunolology, 118, 451.
7. Gul, A. (2005) Behçet's disease is an autoinflammatory disorder. Current Drug Targets. Inflammation and Allergy, 4, 81.
8. Gul, A., Ozbek, U., Ozturk, C., Inanc, M., Konice, M. & Ozcelik, T. (1996) Coagulation factor V gene mutation increases the risk of venous thrombosis in Behçet's disease. British Journal of Rheumatology, 35, 1178.
9. Harper, K., Balzano, C., Rouvier, E., Mattel, M.G., Lucianni, M.F. & Golstein, P. (1991) CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure and chromosomal location. Journal of Immunology, 147, 1037.
10. Hirohata, S. & Kikuchi, H. (2003) Behçet's disease. Arthritis Research and Therapy, 5, 139.
11. International Study Group for Behçet's Disease. (1990) Criteria for diagnosis of Behçet's disease. Lancet, 335, 1078.
12. Karasneh, J., Hajeer, A.H., Barrett, J., Ollier, W.E., Thornhill, M. & Gul, A. (2003) Association of specific interleukin 1 gene cluster polymorphisms with increased susceptibility for Behçet's disease. Rheumatology, 42, 860.
13. Kim, J.U., Chang, H.K., Lee, S.S., Kim, J.W., Kim, K.T., Lee, S.W. et al. (2003) Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease and rheumatic diseases with vasculitis. Annals of Rheumatic Diseases, 62, 1083.
14. Kim, E.H., Mok, J.W., Bang, D.S., Lee, E.S., Lee, S.N. & Park, K.S. (2003) Intercellular adhesion molecule-1 polymorphisms in Korean patients with Behçet's disease. Journal of Korean Medical Science, 18, 415.
15. Kouki, T., Sawai, Y., Gadrine, C.A., Fisfalen, M.E., Alegre, M.L. & DeGroot, L.J. (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. Journal of Immunology, 165, 6606.
16. Lafage-Pochitaloff, M., Costello, R., Couez, D., Simonetti, J., Mannon, P., Mawas, C. et al. (1990) Human CD28 and CTLA-4 Ig superfamily genes are located on chromosome 2 at bands q33-q34. Immunogenetics, 31, 198.
17. Miller, S.A., Dykes, D.D. & Polesky, H.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16, 1215.
18. Mizuki, N., Ota, M., Kimura, M., Ohno, S., Ando, H., Katsuyama, Y. et al. (1997) Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet's disease. Proceedings of the National Academy of Sciences USA, 94, 1298.
19. Ohno, S., Ohguchi, M., Hirose, S., Matsuda, H., Wakisaka, A. & Aizawa, M. (1982) Close association of HLA-Bw51 with Behçet's disease. Archives of Ophthalmology, 100, 1455.
20. Park, S.H., Park, K.S., Seo, Y.I., Min, D.J., Kim, W.U., Kim, T.G. et al. (2002) Association of MICA polymorphism with HLA-B51 and disease severity in Korean patients with Behçet's disease. Journal of Korean Medical Science, 17, 366.
21. Pirim, I., Atasoy, M., Ikbal, M., Erdem, T. & Aliagaoglu, C. (2004) HLA class I and class II genotyping in patients with Behcet's disease: a regional study of eastern part of Turkey. Tissue Antigens, 64, 293.
22. Sallakci, N., Bacanli, A., Coskun, M., Yavuzer, U., Alpsoy, E. & Yegin, O. (2005) CTLA-4 gene 49A/G polymorphism in Turkish patients with Behçet's disease. Clinical and Experimental Dermatology, 30, 546.
23. Salvarani, C., Boiardi, L., Casali, B., Olivieri, I., Cantini, F., Salvi, F. et al. (2004) Vascular endothelial growth factor gene polymorphisms in Behçet's disease. The Journal of Rheumatology, 31, 1785.
24. Seidl, C., Donner, H., Fischer, B., Usadel, K.H., Seifried, E., Kaltwasser, J.P. et al. (1998) CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigens, 51, 62.
25. Sfikakis, P. & Via, C.S. (1997) Expression of CD28, CTLA4, CD80, and CD86 molecules in patients with autoimmune rheumatic diseases: implications for immunotherapy. Clinical Immunology and Immunopathology, 83, 195.
26. Soylu, M., Ersoz, T.R. & Erken, E. (1992) The association between HLA B5 and ocular involvement in Behçet's disease in southern Turkey. Annals of Ophthalmology, 70, 786.
27. Sperling, A.I. & Bluestone, J.A. (1996) The complexities of T-cell co-stimulation: CD28 and beyond. Immunological Reviews, 153, 155.
28. Verity, D.H., Vaughan, R.W., Kondeatis, E., Madanat, W., Zureikat, H., Fayyad, F. et al. (2000) Intercellular adhesion molecule-1 gene polymorphisms in Behçet's disease. European Journal of Immunogenetics, 27, 73.
29. Verity, D.H., Vaughan, R.W., Madanat, W., Kondeatis, E., Zureikat, H., Fayyad, F. et al. (1999) Factor V Leiden mutation is associated with ocular involvement in Behçet disease. American Journal of Ophthalmology, 128, 352.
30. Verity, D.H., Wallace, G.R., Vaughan, R.W. & Stanford, M.R. (2003) Behçet's disease: from Hippocrates to the third millennium. British Journal of Ophthalmology, 87, 1175.
31. Wallace, G.R., Verity, D.H., Delamaine, L.J., Ohno, S., Inoko, H., Ota, M. et al. (1999) MIC-A allele profiles and HLA class I associations in Behçet's disease. Immunogenetics, 49, 613.
32. Walunas, T.L., Lenschow, D.J., Bakker, J.Y., Linsley, P.S., Freeman, G.J., Gren, J.M. et al. (1994) CTLA-4 can function as a negative regulator of T cell activation. Immunity, 1, 405.
33. Yabuki, K., Ohno, S., Mizuki, N., Ando, H., Tabbara, K.F., Goto, K. et al. (1999) HLA class I and II typing of the patients with Behçet's disease in Saudi Arabia. Tissue Antigens, 54, 273.
34. Yazici, H., Yurdakul, S. & Hamuryudan, V. (1998) Behçet's syndrome. In: Rheumatology (ed. by J.H. Klippel & P.A. Dieppe), p. 7/26.1. Mosby International, London.
35. Yen, J.H., Tsai, W.C., Lin, C.H., Ou, T.T., Hu, C.J. & Liu, H.W. (2004) Cytochrome P450 1A1 and manganese superoxide dismutase gene polymorphisms in Behçet's disease. The Journal of Rheumatology, 31, 736.